Investing
Top Analyst Upgrades and Downgrades (ACTV, AGN, BMY, CAG, COP, DUK, LLY, FRX, MRK, PFE, TIF, ULTA, WPI, YUM)
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Friday.
Active Network Inc. (NYSE: ACTV) raised to Buy at BofA/ML.
Allergan Inc. (NYSE: AGN) started as Buy at Citigroup.
Bristol-Myers Squibb Co. (NYSE: BMY) started as Neutral at Citigroup.
ConAgra Foods Inc. (NYSE: CAG) raised to Buy at Jefferies.
ConocoPhillips (NYSE: COP) started as Outperform at Wells Fargo.
Duke Energy Corp. (NYSE: DUK) maintained Outperform with $76.50 target at Credit Suisse.
Eli Lilly & Co. (NYSE: LLY) started as Buy at Citigroup.
Forest Laboratories Inc. (NYSE: FRX) started as Buy at Citigroup.
Merck & Co. (NYSE: MRK) started as Neutral at Citigroup.
Pfizer Inc. (NYSE: PFE) started as Buy at Citigroup.
Tiffany & Co. (NYSE: TIF) cut to Neutral at BofA/ML.
Ulta Salon Cosmetics & Fragrance Inc. (NASDAQ: ULTA) raised to Outperform at Wells Fargo.
Watson Pharmaceuticals Inc. (NYSE: WPI) reiterated Buy with $100 target and raised estimates at Argus.
Yum! Brands Inc. (NYSE: YUM) cut to Neutral at UBS and cut to Underperform at Raymond James.
JON C. OGG
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.